View : 412 Download: 0
Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium
- Effect of pharmaceutical excipients on aqueous stability of rabeprazole sodium
- Ren S.; Park M.-J.; Sah H.; Lee B.-J.
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- International Journal of Pharmaceutics
- International Journal of Pharmaceutics vol. 350, no. 41276, pp. 197 - 204
- SCIE; SCOPUS
- Document Type
Show the fulltext
- The chemical stability of a proton-pump inhibitor, rabeprazole sodium, was evaluated in simulated intestinal fluid (pH 6.8) containing various 'Generally Recognized As Safe (GRAS)'-listed excipients, including Brij® 58, Poloxamer 188, Cremophor RH40, Gelucire 44/14 and PEG 6000. After incubation at 37 and 60 °C, the amounts of rabeprazole and its degradation product, thioether-rabeprazole, were quantitated by HPLC analysis. The main degradation product was separated and characterized by LC/MS. The degradation of rabeprazole followed first-order kinetics. In the absence of any excipients, the rate constants (k) obtained at 37 and 60 °C were 0.75 and 2.78 h-1, respectively. In contrast, the addition of excipients improved its stability. Among several excipients tested in this study, Brij® 58 displayed the greatest stabilizing effect. For instance, at 37 and 60 °C, Brij® 58 reduced the k values to 0.22 and 0.53 h-1, respectively. The stabilizing mechanisms of these hydrophilic polymeric excipients with optimal HLB values could be partially explained in terms of their solubilizing efficiency and micellar formation for thioether-rabeprazole. In conclusion, rabeprazole formulations that contain suitable excipients would improve its stability in the intestinal tract, thereby maximizing bioavailability. © 2007.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.